On June, 5 Analysts See $0.84 EPS for Calavo Growers, Inc. (CVGW)

May 17, 2018 - By Don Salinas

Calavo Growers, Inc. (NASDAQ:CVGW) Corporate Logo
During 2017 Q4 the big money sentiment decreased to 1.23. That’s change of 0.42, from 2017Q3’s 1.65. 11 investors sold all, 62 reduced holdings as Calavo Growers, Inc. ratio dived. 55 increased positions while 35 funds took positions. Funds hold 15.14 million shares thus 2.63% less from 2017Q3’s 15.54 million shares.
Chicago Equity Prtnrs Ltd Limited Liability Company has 16,995 shs. State Of Tennessee Treasury Department reported 12,072 shs. Weiss Multi accumulated 0.1% or 45,000 shs. Illinois-based Blair William & Com Il has invested 0% in Calavo Growers, Inc. (NASDAQ:CVGW). New York-based Catalyst Ltd Limited Liability Company has invested 0.03% in Calavo Growers, Inc. (NASDAQ:CVGW). Amundi Pioneer Asset Mngmt holds 0.01% or 44,253 shs in its capital. Nj State Employees Deferred Compensation Plan has invested 0.13% in Calavo Growers, Inc. (NASDAQ:CVGW). Metropolitan Life New York accumulated 5,003 shs or 0.01% of the stock. Eagle Asset invested in 0.02% or 44,284 shs. Gotham Asset Limited Com holds 8,150 shs. Ny State Common Retirement Fund holds 0% of its capital in Calavo Growers, Inc. (NASDAQ:CVGW) for 24,196 shs. Rhumbline Advisers owns 0.01% invested in Calavo Growers, Inc. (NASDAQ:CVGW) for 36,242 shs. Quantbot Limited Partnership has 0% invested in Calavo Growers, Inc. (NASDAQ:CVGW) for 1 shs. Dimensional Fund Advsr Limited Partnership reported 646,272 shs. 31,199 were reported by Bahl & Gaynor.

Calavo Growers, Inc. had 4 selling transactions and 0 insider buys since December 26, 2017. This’s net activity of $2.17 million. 7,500 shs were sold by LEAVENS J LINK, worth $692,333. $598,988 worth of stock was sold by Browne Michael A on Thursday, March 29. Another trade for 1,000 shs valued at $85,050 was sold by Brown Marc Laurence.

Calavo Growers, Inc. (NASDAQ:CVGW)’s quarterly earnings will be reported on June, 5., Faxor reports. Analysts expect change of 13.51 % or $0.10 from previous year’s $0.74 EPS compared to current’s $0.84 EPS. If the current EPS of $0.84 is accurate, CVGW’s profit could reach $14.74M. Analysts at Wall Street see Calavo Growers, Inc.’s 55.56 % EPS growth compared to $0.54 EPS for last quarter. CVGW is reaching $96.65 during the last trading session, after increased 3.15%.Calavo Growers, Inc. has 274,815 shares volume, 84.29% up from normal. CVGW is uptrending and has moved 52.39% since May 17, 2017. The stock outperformed the S&P 500 by 40.84%.

Calavo Growers, Inc. (NASDAQ:CVGW) Ratings Coverage

A total of 3 analysts rate Calavo Growers (NASDAQ:CVGW) as follows: 3 “Buy”, 0 “Hold” and 0 “Sell”. Тherefore 100% are bullish. (NASDAQ:CVGW) has 4 ratings reports on May 17, 2018 according to StockzIntelligence. In Wednesday, December 6 report Stephens maintained the stock with “Buy” rating. On Wednesday, March 21 the company was maintained by Stephens. On Thursday, March 8 the company was maintained by Buckingham Research.

Calavo Growers, Inc. markets and distributes avocados, prepared avocados, and other perishable foods to food distributors, produce wholesalers, supermarkets, convenience stores, and restaurants worldwide.The company has $1.70 billion market cap. It operates in three divisions: Fresh Products, Calavo Foods, and RFG.The P/E ratio is 43.17. The Fresh products segment distributes avocados and other fresh produce products; and procures avocados grown in Mexico, as well as various other commodities, including tomatoes, papayas, and pineapples.

There’s a significant Calavo Growers, Inc. (NASDAQ:CVGW) news published by Globenewswire.com. It’s an article titled: “Recent Analysis Shows Lancaster Colony, Calavo Growers, Acuity Brands, Cyclacel Pharmaceuticals, Enbridge …” on May 04, 2018.

Calavo Growers, Inc. (NASDAQ:CVGW) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: